One Pager as on May 31, 2026
![]() | GOVERNMENT POLICIES: Policies like Make in India, Atmanirbhar Bharat, Production Linked Incentives etc. could drive manufacturing in India. |
![]() | GLOBAL TAILWINDS:Diversification of production away from China to avoid supply chain shocks and overdependence could boost manufacturing in India |
![]() | IMPROVED INFRASTRUCTURE: Push for improved physical and industrial infrastructure, increased power capacity could be an important enabler for manufacturing. |
![]() | EXPORT PROMOTION: Focusing on companies that are manufacturing finished goods for export. |
![]() | IMPORT SUBSTITUTION: Substitution of imported finished goods and raw materials with domestically manufactured products and materials |
![]() | DOMESTIC CONSUMPTION: Focus on Production of goods for used by domestic businesses and retail consumers. |
| Sector | MMMF* | Nifty India Manufacturing TRI |
| Automobile And Auto Components | 24.30% | 25.94% |
| Capital Goods | 23.93% | 20.94% |
| Metals & Mining | 11.67% | 16.31% |
| Healthcare | 9.35% | 17.27% |
| Chemicals | 5.55% | 6.69% |
#For the equity portion
*Mahindra Manulife Manufacturing Fund
Data as on May 31, 2026
| Security | % to Net Assets |
| Tata Steel Limited | 6.24% |
| Mahindra & Mahindra Limited | 5.08% |
| Reliance Industries Limited | 4.79% |
| Hindalco Industries Limited | 4.61% |
| Sun Pharmaceutical Industries Limited | 3.79% |
| Divi's Laboratories Limited | 3.79% |
| Bharat Electronics Limited | 3.78% |
| Shriram Pistons and Rings Ltd | 3.30% |
| Bajaj Auto Limited | 3.14% |
| Samvardhana Motherson International Limited | 2.45% |
| Total | 40.97% |
Data as on May 31, 2026
| Fresh Additions | Complete Exits |
| Security | Security |
| Powerica Limited | Powerica Ltd |
| Blue Star Limited | Havells India Limited |
| - | SRF Limited |
| - | - |
| - | - |
| - | - |
| Turnover Ratio (Last 1 year) | 0.24 |
^Benchmark ^^Additional Benchmark. Inception/Allotment date: 24-Jun-24. CAGR – Compounded Annual Growth Rate.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments.
Since inception returns of the scheme is calculated on face value of Rs. 10 invested at inception. The performance details provided above are of Growth Option under Regular and Direct Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. *Based on standard investment of Rs. 10,000 made at the beginning of the relevant period.
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 24-Jun-24.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments.
Returns greater than 1 year period are compounded annualized. For SIP returns, monthly investment of equal amounts invested on the 1st business day of every month has been considered. CAGR Returns (%) are computed after accounting for the cash flow by using the XIRR method (investment internal rate of return).
^Benchmark CAGR – Compounded Annual Growth Rate.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments.
The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Renjith Sivaram manages 5 schemes of Mahindra Manulife Mutual Fund and Mr. Navin Matta manages 4 schemes of Mahindra Manulife Mutual Fund . The performance data for the schemes which have not completed one year has not been provided.
Note: The performance data of Mahindra Manulife Innovation Opportunities Fund has not been provided as the scheme has not completed 1 year since inception. The said Scheme is managed by
Mr. Renjith Sivaram & Ms. Kirti Dalvi.
Note: Performance as on May 29,2026.
Note: As May 30 & 31, 2026 were non-business days, the schemes returns disclosed above is as on May 29, 2026.
This product is suitable for investors who are seeking*:
• Long term capital appreciation;
• Investment in equity and equity-related securities of
companies engaged in manufacturing theme.

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.